Copy Link Print Information

Voxalatamab

(Synonyms: JNJ-63898081; JNJ-081)
Avis client

Based on 1 Customer Validation

Voxalatamab (JNJ-63898081) is a bispecific IgG4 antibody targeting PSMA and CD3. Voxalatamab attacks PSMA-expressing tumor cells by activating T cells. Voxalatamab has anticancer activity and is being studied for the treatment of solid tumors such as prostate cancer.

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

  • Pureté: 99.90%
  • CAS No.: 2411871-58-2
  • Masse moléculaire:144.68 kDa
  • Stockage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Voxalatamab
  • Experimental Validation Results for Voxalatamab
  • Experimental Validation Results for Voxalatamab
  • Experimental Validation Results for Voxalatamab
  • Voxalatamab Chemical Structure
    Voxalatamab Chemical Structure
CAS No.: 2411871-58-2
Size
Prix
Stock
Quantité
Amount: USD 0.00
Please select quantity
or
or

* Veuillez sélectionner la quantité avant d'ajouter des articles.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Voxalatamab Product Recommendations:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Trouvez votre distributeur local Your local distributor: Hycultec GmbHHycultec
  • Activité biologique
  • Chemical Information
  • Pureté et documentation
  • Références
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products
Keywords
100 mg

Obtenir un devis En stock

Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Enregistrer
Sign in to MedChemExpress
Enregistrer un nouveau compte

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    Ig(G4-kappa_G4-lambda2)

  • 1/16

    Immobilized Human CD3 epsilon/CD3e Protein (ECD, His Tag) can bind Voxalatamab. The EC50 for this effect is 4.79 ng/mL.

  • 1/16

    Immobilized Human PSMA/FOLH1 Protein can bind Voxalatamab. The EC50 for this effect is 47.87 ng/mL.

  • 1/16

    Flow cytometric analysis of 1×106 Jurkat cells labelling CD3E (red) with Voxalatamab (HY-P99517). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. Alexa Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG4 kappa Isotype Control (HY-P99003, blue) was used as the isotype control.

  • Voxalatamab Chemical Structure
    1/16
  • Voxalatamab
  • Immobilized Human CD3 epsilon/CD3e Protein (ECD, His Tag) can bind Voxalatamab. The EC50 for this effect is 4.79 ng/mL.
  • Immobilized Human PSMA/FOLH1 Protein can bind Voxalatamab. The EC50 for this effect is 47.87 ng/mL.
  • Flow cytometric analysis of 1×106 Jurkat cells labelling CD3E (red) with Voxalatamab (HY-P99517). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. Alexa Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG4 kappa Isotype Control (HY-P99003, blue) was used as the isotype control.
  • Ig(G4-kappa_G4-lambda2)